Twist Bioscience (TWST) Short term Debt (2018 - 2021)
Historic Short term Debt for Twist Bioscience (TWST) over the last 4 years, with Q4 2021 value amounting to $9.1 million.
- Twist Bioscience's Short term Debt rose 17248.72% to $9.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $9.1 million, marking a year-over-year increase of 17248.72%. This contributed to the annual value of $1.6 million for FY2021, which is 5343.53% down from last year.
- Twist Bioscience's Short term Debt amounted to $9.1 million in Q4 2021, which was up 17248.72% from $1.6 million recorded in Q3 2021.
- Twist Bioscience's 5-year Short term Debt high stood at $9.1 million for Q4 2021, and its period low was $1.6 million during Q3 2021.
- In the last 4 years, Twist Bioscience's Short term Debt had a median value of $3.3 million in 2018 and averaged $3.5 million.
- Data for Twist Bioscience's Short term Debt shows a peak YoY increase of 17248.72% (in 2021) and a maximum YoY decrease of 5343.53% (in 2021) over the last 5 years.
- Quarter analysis of 4 years shows Twist Bioscience's Short term Debt stood at $3.3 million in 2018, then changed by 0.0% to $3.3 million in 2019, then changed by 0.0% to $3.3 million in 2020, then soared by 172.49% to $9.1 million in 2021.
- Its Short term Debt was $9.1 million in Q4 2021, compared to $1.6 million in Q3 2021 and $2.4 million in Q2 2021.